These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31314139)

  • 1. Allergic contact dermatitis caused by amorolfine in a nail lacquer.
    Romita P; Stingeni L; Hansel K; De Prezzo S; Ambrogio F; Bonamonte D; Foti C
    Contact Dermatitis; 2019 Nov; 81(5):407-408. PubMed ID: 31314139
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
    Feng X; Xiong X; Ran Y
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allergic contact dermatitis due to amorolfine in nail lacquer].
    Pérez-Varela L; Goday-Buján J; Piñeyro-Molina F; Costa-Domínguez C
    Actas Dermosifiliogr; 2010 Apr; 101(3):281-3. PubMed ID: 20398612
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly.
    Reinel D; Clarke C
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():44-9. PubMed ID: 1458665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact dermatitis from amorolfine-containing cream and nail lacquer.
    Kramer K; Paul E
    Contact Dermatitis; 1996 Feb; 34(2):145. PubMed ID: 8681549
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
    Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
    J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer.
    Downs AM; Lear JT; Archer CB
    Br J Dermatol; 1999 Mar; 140(3):555. PubMed ID: 10233295
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic contact dermatitis caused by undecylenic acid in an antifungal nail solution.
    Ochando-Ibernón G; Schneller-Pavelescu L; Vergara de Caso EF; Silvestre-Salvador JF
    Contact Dermatitis; 2019 May; 80(5):313-314. PubMed ID: 30537336
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic contact dermatitis from amorolfine cream.
    Kaneko K; Aoki N; Hata M; Yajima J; Kawana S; Hattori S
    Contact Dermatitis; 1997 Dec; 37(6):307. PubMed ID: 9455644
    [No Abstract]   [Full Text] [Related]  

  • 13. Contact dermatitis caused by efinaconazole solution for treatment of onychomycosis.
    Hirohata A; Hanafusa T; Mabuchi-Kiyohara E; Ikegami R
    Contact Dermatitis; 2015 Sep; 73(3):190-2. PubMed ID: 25960269
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations.
    Mensing H; Polak-Wyss A; Splanemann V
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():29-32. PubMed ID: 1458661
    [No Abstract]   [Full Text] [Related]  

  • 15. Onychomadesis caused by efinaconazole.
    Yamaguchi Y; Hoshina D; Furuya K
    Contact Dermatitis; 2017 Jan; 76(1):57-58. PubMed ID: 27957751
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use.
    Reinel D
    Dermatology; 1992; 184 Suppl 1():21-4. PubMed ID: 1532336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
    Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ
    Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
    Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
    Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet.
    Oiso N; Tatebayashi M; Kawada A
    Contact Dermatitis; 2017 Jan; 76(1):53-54. PubMed ID: 27957750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.